ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00948259
Recruitment Status : Completed
First Posted : July 29, 2009
Last Update Posted : November 11, 2009
Sponsor:
Information provided by:
Noscira SA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : November 2009